Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats

Critical Care Medicine

Volumn 39, Issue 6, 2011, Pages 1448-1453

  Ryang, Yu Mi ^a,b   Fahlenkamp, Astrid V ^b,c   Rossaint, Rolf ^b   Wesp, Dominik ^b   Loetscher, Philip D ^b   Beyer, Cordian ^c   Coburn, Mark ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

argon; middle cerebral artery occlusion; neuroprotection

Indexed keywords

ARGON; TRIPHENYLTETRAZOLIUM;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASAL GANGLION; BEHAVIOR; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; FACE MASK; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RAT; REPERFUSION; STAINING; SURVIVAL RATE;

EID: 79957637198     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31821209be     Document Type: Article

References (30)

1. Sosin DM, Sniezek JE, Thurman DJ: Incidence of mild and moderate brain injury in the United States, 1991. Brain Inj 1996; 10:47-54. (Pubitemid 26093550)
2. Moustafa RR, Baron JC: Pathophysiology of ischaemic stroke: Insights from imaging, and implications for therapy and drug discovery. Br J Pharmacol 2008;153(Suppl 1):S44-S54. (Pubitemid 351340992)
3. Chopp M, Li Y: Treatment of stroke and intracerebral hemorrhage with cellular and pharmacological restorative therapies. Acta Neurochir Suppl 2008; 105:79-83.
4. Ma D, Wilhelm S, Maze M, et al. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002; 89:739-746. (Pubitemid 35277224)
5. Coburn M, Maze M, Franks NP: The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 2008; 36:588-595. (Pubitemid 351158637)
6. Preckel B, Mullenheim J, Moloschavij A, et al. Xenon administration during early reperfusion reduces infarct size after regional ischemia in the rabbit heart in vivo. Anesth Analg 2000; 91:1327-1332.
7. Pavlov BN, Grigoriev AI, Smolin VV, et al. Investigations of different hyperoxic, hypoxic and normoxic oxygen-argon gaseous mixtures under different barometric pressure and respiration periods. In: High Pressure Biology and Medicine. Bennet PB, Demchenko L, Marquis RE (Editors). Rochester, MN, University of Rochester Press, 1997, pp 133-142.
8. Jawad N, Rizvi M, Gu J, et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009; 460: 232-236.
9. Loetscher PD, Rossaint J, Rossaint R, et al. Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 2009; 13:R206.
10. Sanders RD, Ma D, Maze M: Argon neuroprotection. Crit Care 2010; 14:117.
11. Koizumi J, Yoshida Y, Nakazawa T, et al. Experimental studies of ischemic brain edema, I: A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jpn J Stroke 1986; 8:1-8.
12. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20:84-91. (Pubitemid 19040218)
13. Kramer M, Dang J, Baertling F, et al. TTC staining of damaged brain areas after MCA occlusion in the rat does not constrict quantitative gene and protein analyses. J Neurosci Methods 2010; 187:84-89.
14. Belayev L, Alonso OF, Busto R, et al. Middle cerebral artery occlusion in the rat by intraluminal suture. Neurological and pathological evaluation of an improved model. Stroke 1996;27:1616 -1622; discussion 1623.
15. Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: Evaluation of the model and development of a neurologic examination. Stroke 1986; 17:472-476. (Pubitemid 16085691)
16. Swanson RA, Morton MT, Tsao-Wu G, et al. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab 1990; 10:290-293. (Pubitemid 20096202)
17. Belayev L, Khoutorova L, Deisher TA, et al. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke 2003; 34:758-763. (Pubitemid 36307407)
18. Zausinger S, Hungerhuber E, Baethmann A, et al. Neurological impairment in rats after transient middle cerebral artery occlusion: A comparative study under various treatment paradigms. Brain Res 2000; 863:94-105. (Pubitemid 30201588)
19. Dickinson R, Franks NP: Bench-to-bedside review: Molecular pharmacology and clinical use of inert gases in anesthesia and neuroprotection. Crit Care 2010; 14:229.
20. Franks NP: General anaesthesia: From molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 2008; 9:370-86. (Pubitemid 351556044)
21. Abraini JH, Kriem B, Balon N, et al. Gammaaminobutyric acid neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg 2003; 96:746-749. (Pubitemid 36245563)
22. Bickler PE, Warner DS, Stratmann G, et al. Gamma-aminobutyric acid-A receptors contribute to isoflurane neuroprotection in organotypic hippocampal cultures. Anesth Analg 2003; 97:564-571. (Pubitemid 36899766)
23. Schwartz-Bloom RD, Miller KA, Evenson DA, et al. Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: An ultrastructural study. Neuroscience 2000; 98:471-484. (Pubitemid 30408167)
24. Ascher P, Nowak L: Electrophysiological studies of NMDA receptors. Trends Neurol Sci 1987; 10:8.
25. Zhang F, Li C, Wang R, et al. Activation of GABA receptors attenuates neuronal apoptosis through inhibiting the tyrosine phosphorylation of NR2A by Src after cerebral ischemia and reperfusion. Neuroscience 2007; 150:938-949. (Pubitemid 350235792)
26. Diemer NH, Valente E, Bruhn T, et al. Glutamate receptor transmission and ischemic nerve cell damage: Evidence for involvement of excitotoxic mechanisms. Prog Brain Res 1993; 96:105-123. (Pubitemid 23185287)
27. Lipton P: Ischemic cell death in brain neurons. Physiol Rev 1999; 79:1431-1568. (Pubitemid 29473320)
28. David HN, Haelewyn B, Rouillon C, et al. Neuroprotective effects of xenon: A therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J 2008; 22:1275-1286. (Pubitemid 351519980)
29. Xu J, Li C, Yin XH, et al. Additive neuroprotection of GABA A and GABA B receptor agonists in cerebral ischemic injury via PI- 3K/Akt pathway inhibiting the ASK1-JNK cascade. Neuropharmacology 2008; 54: 1029-1040.
30. Galeffi F, Sinnar S, Schwartz-Bloom RD: Diazepam promotes ATP recovery and prevents cytochrome C release in hippocampal slices after in vitro ischemia. J Neurochem 2000; 75:1242-1249 (Pubitemid 30660514)